Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery
Author
Source
Case Reports in Anesthesiology
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-12-24
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Anesthetic management for patients with certain neuromuscular disorders may be challenging due to contraindications to triggering agents secondary to increased susceptibility for malignant hyperthermia (MH).
Inclusion body myositis (IBM) is an inflammatory muscle disease that causes concern for the anesthesiologist due to potential respiratory muscle weakness and hyperkalemia with succinylcholine.
Elevated serum creatinine kinase levels found in IBM also raise the possibility of increased susceptibility to MH.
This case report describes a successful anesthetic course with special considerations in a patient with IBM undergoing general anesthesia for coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB) using total intravenous anesthesia (TIVA).
American Psychological Association (APA)
Kim, Uoo. 2020. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1145955
Modern Language Association (MLA)
Kim, Uoo. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1145955
American Medical Association (AMA)
Kim, Uoo. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1145955
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1145955